Skip to content

Registry to Evaluate the ROX COUPLER in Patients With Resistant or Uncontrolled Hypertension

ROX CONTROL HTN Registry: To Evaluate the ROX Coupler in Patients With Resistant or Uncontrolled Hypertension

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01885390
Enrollment
83
Registered
2013-06-25
Start date
2014-03-01
Completion date
2019-05-05
Last updated
2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, High, Blood Pressure, Resistant, Blood Pressure, Uncontrolled, Hypertension

Keywords

Hypertension, High blood pressure, Resistant blood pressure, Uncontrolled blood pressure

Brief summary

The purpose of this registry is to evaluate the safety and performance of the ROX COUPLER in patients with treatment-resistant or uncontrolled hypertension.

Interventions

The COUPLER will be used to create an anastomosis in the iliac region (between the iliac artery and vein).

Sponsors

ROX Medical, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of resistant or uncontrolled hypertension must be made on the basis of current findings, medical history, and physical examination.

Exclusion criteria

* Any serious medical condition that may adversely affect the patient's safety, limit the subject's ability to participate in the registry, comply with follow-up requirements, or impact the scientific integrity of the study.

Design outcomes

Primary

MeasureTime frameDescription
Change in ambulatory daytime mean systolic blood pressureBaseline, 6 monthsChange in mean ambulatory daytime systolic blood pressure at six months as compared to Baseline.

Secondary

MeasureTime frameDescription
Change in ambulatory daytime mean diastolic blood pressureBaseline, 6 monthsChange in mean ambulatory daytime diastolic blood pressure at six months as compared to Baseline.

Countries

Belgium, Netherlands, United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026